Trospium chloride clinical trials
A product of Trospium; its studies count on that page too.
How each study uses trospium chloride is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the trospium chloride studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 28 May 2004 · SANCTURA · NDA 021595 (FDA, Drugs@FDA)
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
18 studies that test it; most in 2025 (6)
| Year | Studies |
|---|---|
| 2009 | 3 |
| 2010 | 2 |
| 2013 | 1 |
| 2016 | 1 |
| 2020 | 1 |
| 2025 | 6 |
| 2026 | 4 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 14 · Other 4
Allergan (5) · Bristol-Myers Squibb (5) · Karuna Therapeutics, Inc., a Bristol Myers Squibb company (3) · Karuna Therapeutics (1) · University of North Carolina, Chapel Hill (1) · Collaborative Neuroscience Research, LLC (1) · New York State Psychiatric Institute (1) · Mansoura University (1)
Often tested with
Tested in the same studies.
Related medicines
As reviewed, each with the page that says it.
- A salt or form of Trospium
- One of Cholinergic Antagonists source
- One of Antimuscarinics source
- One of Parasympatholytics source
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 4, 1 in phase 3
Studies that test trospium chloride, phase 3 first.
- Jun 2027A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or LamotriginePhase 3 · Bristol-Myers Squibb
- Dec 2026A Study to Evaluate the Effects of CYP2D6 Phenotypes on the Pharmacokinetics of Xanomeline Following KarXT Administration in Healthy Adult ParticipantsPhase 1 · Karuna Therapeutics, Inc., a Bristol Myers Squibb company
- Mar 2027A Study to Evaluate Novel KarX and KarT Prototypes Versus the KarXT and KarX-EC Reference Following Single Doses, Explore the Effect of Food After Multiple Doses of Selected Prototypes, and Evaluate Alternative Formulations of KarX and KarXT Following Single and Multiple Ascending DosesPhase 1 · Bristol-Myers Squibb
- Apr 2027A PET/MRI Study of Cobenfy on Dopamine Transmission in SchizophreniaPhase 1/2 · New York State Psychiatric Institute
Studies
Open first, then newest update. How each study uses trospium chloride is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 18
- A Study to Evaluate the Effect of KarXT on Urological SafetyRecruitingPhase 4Bristol-Myers SquibbNCT07221877Written as Xanomeline/trospium chloride
- A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)RecruitingPhase 3Bristol-Myers SquibbNCT07011732Written as Xanomeline/Trospium Chloride Capsule
- A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or LamotrigineRecruitingPhase 3Bristol-Myers SquibbNCT07140913Written as Xanomeline/Trospium Chloride
- A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's DiseaseRecruitingPhase 3Bristol-Myers SquibbNCT07011745Written as Xanomeline/Trospium Chloride Capsule
- Relapse Prevention Trial Evaluating KarXT Treatment in SchizophreniaRecruitingPhase 3Karuna Therapeutics, Inc., a Bristol Myers Squibb companyNCT07686263Written as Xanomeline/Trospium Chloride
- A Study to Evaluate the Effects of CYP2D6 Phenotypes on the Pharmacokinetics of Xanomeline Following KarXT Administration in Healthy Adult ParticipantsRecruitingPhase 1Karuna Therapeutics, Inc., a Bristol Myers Squibb companyNCT07204418Written as Xanomeline/ Trospium Chloride
- A Study to Evaluate Novel KarX and KarT Prototypes Versus the KarXT and KarX-EC Reference Following Single Doses, Explore the Effect of Food After Multiple Doses of Selected Prototypes, and Evaluate Alternative Formulations of KarX and KarXT Following Single and Multiple Ascending DosesRecruitingPhase 1Bristol-Myers SquibbNCT07063342Written as Xanomeline/Trospium Chloride Capsule
- A PET/MRI Study of Cobenfy on Dopamine Transmission in SchizophreniaRecruitingPhase 1/2New York State Psychiatric InstituteNCT07423546Written as Xanomeline and trospium chloride (KarXT)
- An 8-week Open-label Study of an Accelerated and Slower Switching to Xanomeline/Trospium Following Atypical Antipsychotic Treatment in Participants With SchizophreniaNot yet recruitingPhase 4Collaborative Neuroscience Research, LLCNCT06924255Written as Xanomeline and Trospium Chloride
- KarXT Concentrations in the Breast Milk and Plasma of Lactating FemalesCompletedPhase 4Karuna Therapeutics, Inc., a Bristol Myers Squibb companyNCT07257120Written as Xanomeline/trospium chloride
- Trospium Chloride vs Tamsulosin in Treatment of Ureteral Stent Related Symptoms:SuspendedNot applicableMansoura UniversityNCT03709992Written as Trospium Chloride
- Pilot Study Comparing Effects of Xanomeline Alone to Xanomeline Plus TrospiumCompletedPhase 1Karuna TherapeuticsNCT02831231Written as Trospium chloride
- The Effect of Anticholinergics on Cognitive Function in the ElderlyCompletedPhase 4University of North Carolina, Chapel HillNCT01922115Written as Trospium Chloride
- Sanctura Muscarinic Receptor Antagonist Resists Transport (SMART-II) TrialCompletedPhase 4AllerganNCT01178827Written as trospium chloride
- Sanctura Muscarinic Receptor Antagonist Resists Transport (SMART) TrialCompletedPhase 4AllerganNCT00863551Written as Trospium Chloride
- Efficacy of Sanctura XR (Trospium Chloride) for Reducing Overactive Bladder Symptoms in Female Subjects Refractory to Detrol LA (Tolterodine Tartrate Extended Release) DailyCompletedPhase 4AllerganNCT01089751Written as trospium chloride
- Trospium Chloride XR in Obese Female Patients With Overactive BladderCompletedPhase 4AllerganNCT00932022Written as Trospium Chloride, Extended Release (XR)
- Safety and Tolerability of Trospium Chloride and Metformin Hydrochloride in Healthy SubjectsCompletedPhase 1AllerganNCT00986401Written as Trospium Chloride (Sanctura XR®)
Given beside what is tested · 10 — trospium chloride is usual care or a partner of the new treatment
- An Extension Study to Assess Long-Term Safety and Tolerability of Adjunctive KarXT in Subjects With Inadequately Controlled Symptoms of SchizophreniaCompletedPhase 3Karuna Therapeutics, Inc., a Bristol Myers Squibb companyNCT05304767Written as Xanomeline and Trospium Chloride Capsules
- A Study to Assess Efficacy and Safety of Adjunctive KarXT in Subjects With Inadequately Controlled Symptoms of SchizophreniaCompletedPhase 3Karuna Therapeutics, Inc., a Bristol Myers Squibb companyNCT05145413Written as Xanomeline and Trospium Chloride Capsules
- A Study to Evaluate the Effects of Lithium, Valproic Acid, and Lamotrigine on the Pharmacokinetics of KarXT and Effects of KarXT on the Pharmacokinetics of Lithium, Valproic Acid, and Lamotrigine in Healthy ParticipantsCompletedPhase 1Karuna Therapeutics, Inc., a Bristol Myers Squibb companyNCT06729970Written as Xanomeline/Trospium Chloride
- A Study to Assess the Efficacy and Safety of KarXT in Acutely Psychotic Hospitalized Chinese Adult Subjects With DSM-5 SchizophreniaCompletedPhase 3Karuna Therapeutics, Inc., a Bristol Myers Squibb companyNCT05919823Written as Xanomeline and Trospium Chloride Capsules
- An Open-label Study to Assess the Long-term Safety, Tolerability, and Efficacy of KarXT in Adult Patients With Schizophrenia (EMERGENT-5)CompletedPhase 3Karuna Therapeutics, Inc., a Bristol Myers Squibb companyNCT04820309Written as Xanomeline and Trospium Chloride Capsules
- A Study to Assess Efficacy and Safety of KarXT in Acutely Psychotic Hospitalized Adult Patients With Schizophrenia (EMERGENT-3)CompletedPhase 3Karuna TherapeuticsNCT04738123Written as Xanomeline and Trospium Chloride Capsules
- An Extension Study to Assess Long-term Safety, Tolerability, and Efficacy of KarXT in Adult Patients With Schizophrenia (EMERGENT-4)CompletedPhase 3Karuna TherapeuticsNCT04659174Written as Xanomeline and Trospium Chloride Capsules
- An Open-label Study to Assess the Long-term Safety, Tolerability, Effectiveness, and Durability of Effect of KarXT in Patients With DSM-5 Diagnosis of SchizophreniaTerminatedPhase 3Karuna TherapeuticsNCT05643170Written as Xanomeline and Trospium Chloride Capsules
- A Study to Assess Efficacy and Safety of KarXT in Acutely Psychotic Hospitalized Adult Patients With Schizophrenia (EMERGENT-2)CompletedPhase 3Karuna TherapeuticsNCT04659161Written as Xanomeline and Trospium Chloride Capsules
- A Study to Assess Safety and Efficacy of KarXT in Adult Patients With SchizophreniaCompletedPhase 2Karuna TherapeuticsNCT03697252Written as Xanomeline and Trospium Chloride Capsules
As the comparator · 2 — what is tested is compared with trospium chloride
- Comparative Effectiveness of Initial OAB Treatment Options Among Older Women at High Risk of FallsCompletedEarly Phase 1The University of Texas Medical Branch, GalvestonNCT05880862Written as Trospium Chloride
- Anticholinergic vs. Botox Comparison StudyCompletedPhase 3NICHD Pelvic Floor Disorders NetworkNCT01166438Written as Trospium chloride
Codes
What other systems call trospium chloride · ClinicalTrials.gg INT002272
- MeSH (NLM) C003330trospium chlorideConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 1E6682427ETROSPIUM CHLORIDEConfirmed FDA, NLM, Wikidata
- RxNorm 38891Confirmed FDA, Wikidata
- Wikidata Q27252312trospium chlorideConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C61995Trospium ChlorideOne source FDA
- DrugBank DBSALT000883One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C003330 | trospium chloride | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 1E6682427E | TROSPIUM CHLORIDE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 38891 | — | Confirmed FDA, Wikidata |
| Wikidata | Q27252312 | trospium chloride | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C61995 | Trospium Chloride | One source FDA |
| DrugBank | DBSALT000883 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.